Raquel Hontecillas's most recent trade in Landos Biopharma Inc was a trade of 250,604 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 3, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Landos Biopharma Inc | Raquel Hontecillas | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 250,604 | 250,604 | - | - | Stock Option (right to buy) |